BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 17198350)

  • 1. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 177Lu-EDTMP: a potential therapeutic bone agent.
    Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
    Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats.
    Xavier Holanda CM; Cavalcanti Jales RL; Almeida Catanho MT; Holanda Leite RC; Lopes de Brito LM; Jales-Junior LH; Brandao KC; Amorim LF; de Brito Tiago GG; Gomes ML; Bernardo-Filho M
    Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):761-5. PubMed ID: 12619972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (99m)Tc-interleukin-8 for imaging acute osteomyelitis.
    Gratz S; Rennen HJ; Boerman OC; Oyen WJ; Burma P; Corstens FH
    J Nucl Med; 2001 Aug; 42(8):1257-64. PubMed ID: 11483689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
    Moore AE; Hain SF; Blake GM; Fogelman I
    J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of skeletal tracer kinetics. III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow.
    Sagar VV; Piccone JM; Charkes ND
    J Nucl Med; 1979 Dec; 20(12):1257-61. PubMed ID: 536792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
    Qiu L; Lin J; Nan B; Lv G; Cheng W
    Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of technetium-99m methylene diphosphonate by fractured and osteoporotic bone after a pulse dose of vitamin D3.
    Carr EA; Carroll M; Montes M; Zielezny M
    J Nucl Med; 1985 Apr; 26(4):385-9. PubMed ID: 2984363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study.
    Ozdogan O; Ertay T; Arslan G; Sisman AR; Capa Kaya G; Yilmaz O; Coker C; Gure A; Durak H
    Ann Nucl Med; 2008 Jun; 22(5):357-62. PubMed ID: 18600412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of biodistribution by local versus systemic administration of 99mTc-labeled pamidronate.
    Kumar D; Kumar V; Little DG; Howman-Giles RB; Wong E; Ali SO
    J Orthop Sci; 2006 Oct; 11(5):512-20. PubMed ID: 17013741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of superior bone scintigraphic agent from a series of (99m)Tc-labeled zoledronic acid derivatives.
    Lin J; Qiu L; Cheng W; Luo S; Xue L; Zhang S
    Appl Radiat Isot; 2012 May; 70(5):848-55. PubMed ID: 22381699
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mandiwana V; Kalombo L; Grobler A; Zeevaart JR
    Appl Radiat Isot; 2018 Nov; 141():51-56. PubMed ID: 30170270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of Tc-99m monophosphate complexes in bone and myocardial necrosis in animals.
    Kung HF; Ackerhalt R; Blau M
    J Nucl Med; 1978 Sep; 19(9):1027-31. PubMed ID: 690703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
    Asikoglu M; Durak FG
    Appl Radiat Isot; 2009 Sep; 67(9):1616-21. PubMed ID: 19457677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.